[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 10, 1994

HIV Seroconversion Among High-Risk Women in New York City

Author Affiliations

Medical and Health Research Associates of New York City, Inc
The New York City Department of Health New York, NY

JAMA. 1994;272(6):432-433. doi:10.1001/jama.1994.03520060030017
Abstract

To the Editor.  —Incidence of human immunodeficiency virus (HIV) infections in men and women may predict the magnitude of the acquired immunodeficiency syndrome (AIDS) epidemic, to evaluate the efficacy of prevention programs and to design vaccine trials. Surveys of HIV-1 seroincidence in small samples of high-risk women in the United States outside New York City (NYC) have reported annual rates of 3% to 5%.1,2 Six-month seroincidence among 377 women attending a NYC public clinic for sexually transmitted diseases was 1.7%.3We have estimated the HIV seroconversion rate among high-risk, HIV-negative women in NYC as part of the NYC Perinatal HIV Transmission Collaborative Study. Pregnant women at risk for HIV infection (having a history of injection drug use [IDU], crack cocaine use, or sexual exposure to a man with history of IDU) were enrolled at six NYC hospitals between 1986 and 1992 as controls in a prospective study of

First Page Preview View Large
First page PDF preview
First page PDF preview
×